Tag Archives: MPH

OncoMed Pharmaceuticals (OMED) – Merger Arbitrage – 65%+ Upside

Current price: $0.77

Merger Consideration: $1.26

Upside: 63%

Expiration: expected H1 2019

14 comments

Feb 07, 2019

Disclaimer - nothing on this site should be considered as investment advice or trading recommendation. This is not a financial services site, all information is presented for educational purposes only. Site and its owners take no liabilities or responsibilities for any actions of third parties that were made based on information presented on the site. All readers carry their own due diligence and invest at their own risk.

Main menu

Legal

Terms & Conditions

Privacy

Disclaimer - nothing on this site should be considered as investment advice or trading recommendation. This is not a financial services site, all information is presented for educational purposes only. Site and its owners take no liabilities or responsibilities for any actions of third parties that were made based on information presented on the site. All readers carry their own due diligence and invest at their own risk.